OIA
AMRX icon

OneDigital Investment Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

OneDigital Investment Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-456
Closed -$6K – 1197
2019
Q1 		$6K Buy
456
+77
+20% +$1.02K ﹤0.01% 960
2018
Q4 		$5K Hold
379
– – ﹤0.01% 944
2018
Q3 		$8K Buy
379
+26
+7% +$547 ﹤0.01% 865
2018
Q2 		$6K Buy
+353
New +$6.2K ﹤0.01% 1133

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OneDigital Investment Advisors's AMRX Position: Q2 2019 in Review

OneDigital Investment Advisors sold out of Amneal Pharmaceuticals (AMRX) in Q2 2019, closing a stake of 456 shares — an estimated $6K sold.

OneDigital Investment Advisors first reported a position in AMRX in Q2 2018 and held it in 4 quarters. The position peaked at $8K in Q3 2018. 129 funds tracked by Wall St. Rank hold AMRX as of Q2 2019.

  • OneDigital Investment Advisors reported no remaining Amneal Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • OneDigital Investment Advisors sold 456 Amneal Pharmaceuticals shares in Q2 2019, an estimated $6K.
  • OneDigital Investment Advisors first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 4 quarters.
  • OneDigital Investment Advisors's Amneal Pharmaceuticals position peaked at $8K in Q3 2018.
  • 129 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2019.

Based on OneDigital Investment Advisors's 13F filing for Q2 2019, filed 12 Aug 2019.